Cargando…

O051. Chronic migraine and onabotulinumtoxinA: a prospective study on patients treated at the Headache Centre of the Padua University and analysis of possible predictors of responsivity

Detalles Bibliográficos
Autores principales:	Disco, Caterina, Bellamio, Matteo, Fuccaro, Matteo, Bruno, Martina, Terrin, Alberto, Mainardi, Federico, Zanchin, Giorgio, Maggioni, Ferdinando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715172/ https://www.ncbi.nlm.nih.gov/pubmed/28132290 http://dx.doi.org/10.1186/1129-2377-16-S1-A98

Ejemplares similares

P051. Olfactory migrainous hallucinations: a typical aura manifestation?
por: Bellamio, Matteo, et al.
Publicado: (2015)

P049. Migraine influence on female reproductive life and motherhood
por: Fuccaro, Matteo, et al.
Publicado: (2015)

P065. Cluster headache: when to worry?
por: Bellamio, Matteo, et al.
Publicado: (2015)

P050. Migrainous aura: when to worry?
por: Fuccaro, Matteo, et al.
Publicado: (2015)

O004. Refractory chronic cluster headache responding absolutely to indomethacin
por: Lisotto, Carlo, et al.
Publicado: (2015)

O002. Did Picasso and De Chirico really suffer from migraine auras?
por: Lisotto, Carlo, et al.
Publicado: (2015)

O037. Should aircrafts never land? Headache attributed to aeroplane travel: a new series of 140 patients
por: Mainardi, Federico, et al.
Publicado: (2015)

The borderline between cluster headache and migraine: does cluster-migraine exist?
por: Lisotto, C, et al.
Publicado: (2013)

Cognitive effects of onabotulinumtoxinA in chronic migraine
por: Ho, Susan, et al.
Publicado: (2020)

OnabotulinumtoxinA: Still the Present for Chronic Migraine
por: Baraldi, Carlo, et al.
Publicado: (2023)

A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine
por: Winner, Paul K., et al.
Publicado: (2020)

Efficacy of oxygen inhalation in sumatriptan refractory “high altitude” cluster headache attacks
por: Mampreso, Edoardo, et al.
Publicado: (2009)

Triptan efficacy does not predict onabotulinumtoxinA efficacy but improves with onabotulinumtoxinA response in chronic migraine patients
por: Eren, Ozan E., et al.
Publicado: (2020)

O068. A 2 years prospective evaluation study on onabotulinumtoxinA 195 U in chronic migraine
por: Negro, Andrea, et al.
Publicado: (2015)

OnabotulinumtoxinA in the treatment of refractory chronic cluster headache
por: Lampl, Christian, et al.
Publicado: (2018)

Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
por: Torres-Ferrus, Marta, et al.
Publicado: (2020)

Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
por: Russell, Michael Bjørn
Publicado: (2011)

OnabotulinumtoxinA for chronic migraine: a critical appraisal
por: Gooriah, Rubesh, et al.
Publicado: (2015)

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
por: Frampton, James E., et al.
Publicado: (2018)

Prediction of patient's response to OnabotulinumtoxinA treatment for migraine
por: Parrales Bravo, Franklin, et al.
Publicado: (2019)

Adult Abdominal Migraine Improved by OnabotulinumtoxinA Injections
por: Hermanowicz, Neal
Publicado: (2021)

OnabotulinumtoxinA in chronic migraine: is the response dose dependent?
por: Zandieh, Ali, et al.
Publicado: (2022)

Safety of OnabotulinumtoxinA in the [management of] chronic migraine in pregnancy
por: Smirnoff, Liza
Publicado: (2022)

New recipes for old ingredients: high doses of methylprednisolone and verapamil in cluster headache
por: Zanchin, G, et al.
Publicado: (2013)

P054. Chronic migraine and onabotulinumtoxinA: results from clinical practice
por: Paolucci, Matteo, et al.
Publicado: (2015)

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
por: Rothrock, John F., et al.
Publicado: (2019)

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
por: Bendtsen, Lars, et al.
Publicado: (2018)

OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
por: Onan, Dilara, et al.
Publicado: (2022)

Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
por: Aurora, Sheena, et al.
Publicado: (2011)

Prolonged Effect of OnabotulinumtoxinA on Chronic Migraine in 87 Koreans
por: Byun, Jung-Ick, et al.
Publicado: (2017)

Correction to: OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
por: Frampton, James E., et al.
Publicado: (2018)

OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use
por: Frampton, James E.
Publicado: (2020)

O003. Red ear syndrome: a new form of trigeminal autonomic cephalalgia?
por: Lisotto, Carlo, et al.
Publicado: (2015)

Headache among the educated in the century of enlightment
por: Zanchin, Giorgio, et al.
Publicado: (2004)

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
por: Silberstein, Stephen D., et al.
Publicado: (2020)

Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
por: Diener, H-C, et al.
Publicado: (2014)

Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
por: Rothrock, John F, et al.
Publicado: (2014)

Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety
por: Szok, Délia, et al.
Publicado: (2015)

OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience
por: Chiang, Chia-Chun, et al.
Publicado: (2017)

OnabotulinumtoxinA Is an Effective Treatment for Chronic Migraine in Patients With Comorbid Fibromyalgia
por: Sastre Real, María, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fvu9e485rs0sksb77v0m211ajd